Variable | Patients on Lithium without hypertension or diabetes (Group A1) | Patients on Lithium with hypertension and diabetes (Group A2) | Controls for Group A1 | Controls for Group A2 |
---|---|---|---|---|
(n-24) | (n-23) | (n- 24) | (n-23) | |
Mean ± SD | ||||
Mean age | 42.68 ± 13.3 | 57.68 ± 9.3 | 42.66 ± 14.1 | 57.61 ± 8.9 |
Mean duration of diabetes (in years) | N/A | 3.22 ± 3.3 | N/A | 6.77 ± 3.0 |
Mean duration of hypertension (in years) | N/A | 5.42 ± 5.1 | N/A | 7.85 ± 4.8 |
Range of dose of lithium (mg) | 250 - 1500 | 250 - 1000 | N/A | N/A |
Mean duration of lithium use (in years) | 9.04 ± 5.9 | 11.5 ± 9.3 | N/A | N/A |